Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|76|1|1-9

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.1, 2008-11, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial

By  

Oncology, Vol. 89, Iss. 1, 2015-01 ,pp. : 23-30

Karger

Access to resources Recommend Favorite

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

By  

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 44-52

Karger

Access to resources Recommend Favorite

HCC O‐23: Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 13-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite